Efficacy and safety of Korean Red Ginseng for Patients with Rheumatoid Arthritis: A Randomized Double-Blind Clinical Trial

Hanyang University Seoul Hospital0 个研究点目标入组 80 人开始时间: 待定最近更新: 2019年3月11日

适应症

试验速览

暂无简介。

•1)Person who agreed to participate in this study and signed voluntarily on the written informed consent form
•2)Person who has a diagnosis of adult-onset rhumatoid arthritis as defined by the American College of Rheumatology(ACR) 1987 Criteria or the American College of Rheumatology(ACR)/European League Against Rheumatism(EULAR) 2010 Criteria
•3)Person who aged between 18 and 80
•4)Person who has low disease active score(below 3.2) defined as the 28-joints Disease Assessment Score(DAS 28)
•5)The dose of disease modifying antirheumatic drugs(DMARDs) must have been stable for at least the 8 weeks prior to study entry.

•1)A Pregnant or a breast-feeding woman
•2)Person who has taken a functional food contains ginseng components in 2 months
•3)Person who has a experience of hypersensitivity to a functional food contains ginseng components
•4)Person who has taken contraindicated drug
•·Anti-thrombus drugs: anticoagulants, anti-platelet agents, thrombolytic agents etc
•·Psychiatric drugs
•·Insulin, sulphonylurea drugs
•·Regular stroidcorticoids
•·Herb Extracts
•·Other health functional foods
•5)Person who has a laboratory abnormality
•·White Blood Cell = 3.5 x ?10?^9/L
•·Hemoglobin = 8.5 g/dL
•·Platelet = 100 x ?10?^9/L
•·Creatinine= 2.0 mg/dL
•·Aspartate aminotransferase(AST) or Alanine aminotransferase(ALT) = 2.5 times of upper limits of normal(ULN)

发起方

Hanyang University Seoul Hospital